No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic bleeding complications linked to ticagrelor, a common drug used to treat patients ...

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

Type II: GA101 is a third-generation, fully humanized, glycoengineered Fc region resulting in a much higher antibody-dependent cellular cytotoxicity level. Anti-CD22 Monoclonal Antibodies ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...

Pleasanton, California - Boster Bio Technology unlocks insights into cancer and neurological disorders with high-quality ...

Ebdarokimab is the company's first Class 1 new drug approved for autoimmune diseases and the second non-oncology new drug to receive marketing approval, following ebronucimab (PCSK9). This approval ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that ...